TerminatedNot Applicable

Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection

Stopped: Technical challenges

United States25 participantsStarted 2020-04-15

Plain-language summary

This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study will lead to the development of new robust methods for real-time, continuous monitoring of respiratory function in patients with respiratory failure. In turn, such monitoring methods may enable improvements in the medical management of respiratory failure and timing of interventions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admitted to the hospital * ≥ 18 years of age * Clinically suspected or confirmed COVID-19 infection * Spontaneously breathing * For patients not on supplemental oxygen at their location of residence prior to hospital admission, need for supplemental O2 to maintain SpO2 \>=92% * For patients on supplemental O2 at their location of residence prior to hospital admission, an increase in requirement of supplemental oxygen from baseline Exclusion Criteria: * Intubated patients * Pregnant women * Moribund patients * Patients who are on comfort measures (CMO)

What they're measuring

Endotracheal intubation during present hospitalization, recorded through chart review

Timeframe: Up to three weeks

Trial details

NCT IDNCT04356443

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Respiratory Failure trials